A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers Meeting Abstract


Authors: Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; Ginsberg, M.; Riely, G.; Rudin, C.; Ladanyi, M.; Kris, M.
Abstract Title: A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: cabozantinib; ret rearrangement; ret fusion
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S286
End Page: S287
Language: English
ACCESSION: WOS:000413055800276
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.291
Notes: Meeting Abstract: OA11.05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    434 Rekhtman
  2. Michelle S Ginsberg
    238 Ginsberg
  3. Marc Ladanyi
    1332 Ladanyi
  4. Gregory J Riely
    604 Riely
  5. Romel Somwar
    111 Somwar
  6. Lu Wang
    147 Wang
  7. Mark Kris
    872 Kris
  8. Alexander Edward Drilon
    635 Drilon
  9. Charles Rudin
    495 Rudin
  10. Lukas   Delasos
    14 Delasos
  11. Roger Stephen Smith
    20 Smith
  12. Ai   Ni
    99 Ni